Sources and References

• Monteiro-Riviere and Tran, Nanotoxicology: Progress toward Nanomedicine, 2nd ed., CRC Press.
• Oberdörster, Oberdörster, and Oberdörster, “Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles,” Environmental Health Perspectives, 2005.
• Donaldson and Poland, “Nanotoxicity: challenging the myth of nano-specific toxicity,” Current Opinion in Biotechnology, 2013.
• National Academies, A Research Strategy for Environmental, Health, and Safety Aspects of Engineered Nanomaterials.
• Engineering ethics and practice references as in NE 102.

Chapter 1: Nanotoxicology as an Engineering Discipline

Nanotoxicology studies how engineered nanomaterials interact with living systems and cause harm. While the discipline borrows from classical toxicology, it confronts properties — small size, large specific surface area, biological translocation, and novel interactions with cellular machinery — that require its own methods and mental models. Engineers involved in the design, handling, or deployment of nanomaterials must understand these patterns well enough to apply them in risk assessment and control.

1.1 Exposure Routes

Three principal routes carry nanomaterials into the body: inhalation, dermal contact, and ingestion. Injection — intentional in medicine, accidental in occupational settings — is a fourth. Each route leads to different target tissues, kinetics, and toxicological endpoints.

1.2 Dose Metrics

Classical toxicology expresses dose in mass per kilogram of body weight or mass per volume of air. Nanotoxicology often finds that particle number or surface area correlates better with response, because toxic interactions occur at particle surfaces. An engineer designing an exposure-assessment programme must decide which metric to track and be prepared to report in more than one.

Chapter 2: Inhalation and Pulmonary Effects

2.1 Airway Deposition

Airborne particles deposit by diffusion in the deep lung, by sedimentation in the tracheobronchial tree, and by inertial impaction in the upper airway. The ICRP and MPPD models predict deposition fractions as functions of particle size, breathing rate, and airway geometry. Nanoscale particles (below 100 nm) deposit preferentially in the alveolar region by Brownian diffusion.

2.2 Clearance and Translocation

Deposited particles are cleared by mucociliary escalator in conducting airways and by alveolar macrophage phagocytosis in the deep lung. Particles that resist clearance persist and can translocate across the alveolar epithelium into blood, lymph, and ultimately secondary organs including liver, spleen, and bone marrow. A small fraction of inhaled nanoparticles has been shown to reach the brain via the olfactory nerve.

2.3 Pulmonary Responses

Acute responses include inflammation, oxidative stress, and in rare cases acute lung injury. Chronic responses — especially to durable, biopersistent particles — include fibrosis, granuloma formation, and, for certain high-aspect-ratio materials, mesothelioma-like pathology in rodent studies. The differential toxicity of carbon nanotubes by length, rigidity, and metal impurity content is a concrete example of how fine distinctions in material specification translate into coarse differences in biological effect.

Chapter 3: Dermal Exposure and Skin Penetration

3.1 Skin Barrier

The stratum corneum is an effective barrier against most chemicals. Nanoparticles larger than a few nanometres rarely penetrate intact skin beyond the outer layers; smaller particles, charged particles, and particles on abraded or flexed skin can reach deeper. Hair follicles and sweat ducts provide supplementary pathways.

3.2 Product Considerations

Cosmetics and sunscreens contain nanoscale titanium dioxide and zinc oxide as UV filters. Regulatory reviews generally conclude that, on intact skin, systemic absorption is negligible; photocatalytic activity of some forms raises a distinct concern addressed by surface coatings. Occupational dermal exposure during compounding and filling operations warrants protective clothing and hygiene controls.

Chapter 4: Mechanisms and Endpoints

4.1 Translocation

Nanoparticles that enter the circulation distribute through the body according to size, charge, and surface chemistry. The protein corona that forms in blood plasma alters the effective identity of the particle, often more than the engineered surface does. Reticuloendothelial uptake in liver and spleen dominates for many particle types.

4.2 Cytotoxicity

Cell death by nanoparticles occurs through oxidative stress, membrane damage, lysosomal destabilization, and mitochondrial dysfunction. Dose-dependent effects in vitro are characterized by MTT, WST-1, LDH release, and live–dead imaging assays. Interference of nanoparticles with assay chemistry (absorbance, fluorescence) complicates interpretation; controls with the chosen nanomaterial are essential.

4.3 Mutagenicity

DNA damage is assessed in vitro by comet assay, micronucleus formation, chromosome aberration, and Ames-type mutation assays. Some nanomaterials induce damage at doses well below cytotoxicity, indicating genotoxic rather than merely toxic mechanisms. Direct interaction with nuclear DNA is rare for larger particles; indirect mechanisms via reactive oxygen species and inflammation dominate.

4.4 Neurotoxicity

Nanoparticles reaching the brain can perturb neuronal function, glial response, and blood–brain barrier integrity. Olfactory translocation has been demonstrated for several ultrafine and nanoscale particle types. The long-term neurobehavioural consequences of low-level exposure remain incompletely characterized.

4.5 Carbon Nanotubes as Potential Cancer Hazards

Long, thin, durable carbon nanotubes with physical similarity to asbestos fibres induce mesothelioma-like lesions in rodent peritoneal-cavity studies and inflammation and fibrosis in inhalation studies. The causal framework mirrors asbestos: fibre dimension, durability, and surface reactivity drive response. Shorter, highly functionalized nanotubes and non-fibrous nanocarbons behave differently, reinforcing the need to treat each material specification individually.

Chapter 5: Translating Toxicology to Engineering Practice

5.1 Hazard Classification

Toxicological data inform hazard classification under systems such as the Globally Harmonized System (GHS). Classification by acute toxicity, skin and eye irritation, respiratory sensitization, carcinogenicity, and reproductive toxicity determines labelling, safety-data-sheet content, and handling requirements. Nanomaterials often carry classifications that bulk analogues do not.

5.2 Risk Assessment and Exposure Banding

Where quantitative dose–response data are incomplete, control-banding approaches assign hazard bands based on available information and exposure bands based on process characteristics; the intersection recommends a control level (from general ventilation up to enclosed process with respirator). Tools such as CB Nanotool, Stoffenmanager Nano, and Nanosafer implement variants of this approach.

5.3 Engineering Controls

Controls follow the standard hierarchy. Elimination or substitution replaces the hazardous nanomaterial with a safer alternative. Engineering controls enclose or ventilate the source: glove boxes, fume hoods, biosafety cabinets, HEPA-filtered local exhaust. Administrative controls include training, work practices, and exposure monitoring. PPE — respirators (N95 or higher where justified), gloves, and lab coats — is the final layer.

5.4 Monitoring

Occupational monitoring combines real-time instruments (condensation particle counters, optical particle counters, nanoparticle surface area monitors) with filter-based sampling for later analysis. Task-based sampling attributes elevated concentrations to specific activities; statistical comparison to background distinguishes process emissions from ambient noise.

Chapter 6: Professional Practice and Communication

6.1 Analytical Development

Professional growth in nanotoxicology depends on integrating mechanics, thermodynamics, transport, computation, and data analysis with exposure science and toxicological reasoning. That integration lets an engineer critique journal articles, build defensible analytical reports, and connect laboratory evidence to design decisions.

6.2 Engineering Practice Context

Practical nanotoxicology work often includes laboratory support, analytical evaluation, process monitoring, and risk communication. The central professional habit is reflection tied to evidence: document what was measured, what uncertainty remains, what judgement was exercised, and what ethical obligations follow from the result.

6.3 Communication

Effective toxicology-informed engineering communication means reporting data, uncertainty, and control choices together. A memo recommending a change in laboratory procedure identifies the problem, quantifies the exposure and its uncertainty, explains the proposed control, and estimates its residual risk. A technical presentation balances quantitative evidence with narrative clarity, allowing non-specialist stakeholders to engage with the argument.